BioSpace News Archive

SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19

SAB Biotherapeutics today announced that the U.S. Department of Defense (DoD) has awarded the company an additional $60.5 million in expanded scope for its DiversitAb™ Rapid Response Antibody Program

September 22, 2021
·
10 min read
Drug Development

Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern

Arcturus Therapeutics Holdings Inc. today announced that it has completed dosing of 100 subjects for the Phase 1 portion of the ARCT-154 Phase 1/2/3 clinical trial, which consisted of a two-dose regimen with injections 28 days apart.

September 22, 2021
·
5 min read
Business

COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax’s CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial

Dynavax Technologies Corporation today announced that Clover Biopharmaceuticals (Clover) reported positive data for their protein-based COVID-19 vaccine candidate, SCB-2019

September 22, 2021
·
6 min read
Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference

Sol-Gel Technologies, Ltd. today announced that the Company will participate in the Cantor Global Healthcare Conference, taking place virtually from September 27th – 30th , 2021.

September 22, 2021
·
1 min read
Business

Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research Partnership

Salarius Pharmaceuticals Inc. today announced a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center.

September 22, 2021
·
8 min read
Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Small Cell Lung Cancer Study

Algernon Pharmaceuticals Inc. is pleased to announce that it has filed a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (U.S. FDA) for its investigation of NP-120 (Ifenprodil) for the treatment of small cell lung cancer (SCLC).

September 22, 2021
·
4 min read
Business

RD Fund Launches Opus Genetics with $19M Seed Funding to Advance Gene Therapy Treatments for Blinding Conditions

The Retinal Degeneration Fund announced the launch of Opus Genetics, a patient-focused gene therapy company efficiently developing therapies for orphan inherited retinal diseases.

September 22, 2021
·
5 min read
Drug Development

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Mydecine Innovations Group, a biopharmaceutical company focused on the treatment of mental health and addiction, announced that it has filed its final patent application with the United States Patent and Trademark Office and the World Intellectual Property Organization for one of its lead drug candidates, MYCO-003, which is being developed to offer enhanced treatment of anxiety and post-traumatic stress disorder.

September 22, 2021
·
5 min read
Genetown

Frequency Therapeutics Announces New FX-322 Results Showing That Additional Study Participants Gain Hearing Improvements at Later Time Points

Frequency Therapeutics Announces New FX-322 Results Showing That Additional Study Participants Gain Hearing Improvements at Later Time Points

September 22, 2021
·
9 min read
Biotech Beach

Pancreatic Cancer Action Network To Bring No-Cost Enzyme Therapy To Clinical Trial Participants

Supportive Care Method Will Address Exocrine Pancreatic Insufficiency in Patients Enrolled in PanCAN’s Precision Promise Adaptive Clinical Trial

September 22, 2021
·
3 min read